Found 15 matching trials
Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)
PHASE3This is a multicenter, double-blind, placebo controlled, randomized, outpat...
Location
University of Alabama Hospital (UAB)
Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients
PHASE3This is a study to evaluate the efficacy and safety of multiple doses of ba...
Location
Center for Psychiatric Medicine
A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease
PHASE3The purpose of this study is to assess the long-term safety and tolerabilit...
Location
University of Alabama Hospital
Amyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's Disease
PHASE2This study in individuals with mild to moderate Alzheimer's Disease is desi...
Location
Janssen AI Investigational Site
AAB-001 in Patients With Mild to Moderate Alzheimer's Disease
PHASE2The purpose of this study is to assess the safety and tolerability of multi...
Location
Cleo Roberts Center for Clinical Research / Sun Health Research Institute
AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease
PHASE2This is a multicenter, open-label, long-term extension study in male and fe...
Location
Janssen AI Investigational Site
Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
PHASE3This is a study to evaluate the efficacy and safety of multiple doses of ba...
Location
University of Alabama-Birmingham
Safety Study of Passive Immunization for Patients With Mild to Moderate Alzheimer's Disease
PHASE2This research study will assess whether AAB-001 is safe, well tolerated and...
Location
Pharmacology Research Institute
Study Evaluating Bapineuzumab In Alzheimer Disease Subjects
PHASE2The study will evaluate the safety and effectiveness of bapineuzumab for th...
Location
Pfizer Investigational Site
Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab
PHASE2This study will evaluate the safety and tolerability of bapineuzumab when a...
Location
Banner Alzheimer's Institute